A proliferation-inducing ligand: A new biomarker for non-small cell lung cancer

Experimental Lung Research

Volumn 35, Issue 6, 2009, Pages 486-500

  Sun, Baolan ^a   Wang, Huimin ^a   Wang, Xing ^a   Huang, Hua ^a   Ding, Weifeng ^a   Jing, Rongrong ^a   Shi, Gongsheng ^a   Zhu, Li ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

A proliferation inducing ligand; Non small cell lung cancer; RTQ PCR; Sputum

Indexed keywords

APRIL PROTEIN; BIOLOGICAL MARKER; MESSENGER RNA;

ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG DISEASE; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SPUTUM; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 70849111826     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140902759274     Document Type: Article

References (34)

1. Hahne M, Kataoka T, Schroter M, Hofmann K, Irmler M, Bodmer JL, et al: APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med. 1998;188:1185-1190.
2. Pradet-Balade B, Medema JP, Lopez-Fraqa M, Lozano JC, Kolfschoten GM, Picard A. et al: An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J. 2002;21:5711-5720.
3. Ware CF: APRIL and BAFF connect autoimmunity and cancer. J Exp Med. 2000;192:35-38.
4. Yu G, Boone T, Delaney J, Hawkins N, Kelley M, Ramakrishnan M, et al: APRIL and TALL-1 and receptors BCMA and TACI: System for regulating humoral immunity. Nature Immunol. 2000;1:252-256.
5. Kelly K, Manos E, Jensen G, Nadauld L, Jones DA: APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 2000;60:1021-1027.
6. Roth W, Wagenknecht B, Klumpp A, Naumann U, Hahne M, Tschopp J, et al: APRIL, a new member of the tumor necrosis factor family,modulates death ligand-induced apoptosis. Cell Death Differ. 2001;8:403-410.
7. Novak AJ, Bram RJ, Kay NE, Jelinek DF: Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: A mechanism for survival. Blood 2002;100:2973-2979.
8. Marsters SA, YanM, Pitti RM, Haas PE, Dixit VM, Ashkenazi A: Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol. 2000;10:785-788.
9. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, et al: DCs induce CD40- independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002;3:822-829.
10. Mukhopadhyay A., Ni J, Zhai Y, Yu GL, Aggarwal BB: Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem. 1999;274:15978-15981.
11. Nardelli B, et al: Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001;97:198-204.
12. Moreaux J, et al: The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 2005;106:1021-1030.
13. Deshayes F, Lapree G, Portier A, Richard Y, Pencalet P, Mahieu-Caputo D, et al: Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor. Oncogene. 2004;15:3005-3012.
14. Okano H, Shiraki K, Yamanaka Y, Inoue H, Kawakita T, Saitou Y, et al: Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization. World J Gastroenterol. 2005;11:4650-4654.
15. Zhang D-l, Ju S-q, Shi J, Wang H-M, Ni H-B, Su J-Y, et al: Measurement of the expression level of APRIL and its receptors in liver cancer tissue by real-time fluorescence quantitative method. Chin J Lab Med. 2005;28:433-436.
16. Mhawech-Fauceqlia P, Kaya G, Sauter G, Mckee T, Donze O, Schwaller J, et al: The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol. 2006;80:697-704.
17. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
18. Fielding P, Turnbull L, Prime W, Walshaw M, Field JK: Heterogenous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: A clinical marker of early lung cancer detection. Clin Cancer Res. 1999;5:4048-4052.
19. Albanell J, Lonardo F, Rusch V, Engelhardt M, Langenfeld J, HanW, et al: High telomerase activity in primary lung cancers: Association with increased cell proliferation rates and advanced pathologic stage. J Natl Cancer Inst. 1997;89:1609-1615.
20. Jang SJ, Soria JC,Wang L, Hassan KA, Morice RC,Walsh GL, et al: Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res. 2002;61:7959-7963.
21. Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC, Kelsey KT: Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst. 1999;91:2032-2038.
22. Lacroix J, Becker HD, Woerner SM, Rittgen W, Drings P, von Knebel Doeberitz M: Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-spefic RT-PCR. Int J Cancer 2001;92:1-8.
23. Tora M, Barbera VM, Real FX: Detection of HuD transcripts by means of reverse transcriptase and polymerase chain reaction: Implications for the detection of minimal residual disease in patients with small cell lung cancer. Cancer Lett. 2000;161:157-164.
24. Ahrendt SA, Decker PA, Doffek K, Wang B, Xu L, Demeure MJ, et al: Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer. Cancer Res. 2000;60:2488-2491.
25. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al: Measurement of inflammatory indices in induced sputum: Effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996,9:1174-1180
26. Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155-168.
27. Shi J, Zhang D, Cui Z, et al: Expression of a proliferation-inducing ligand and its receptors in different tumors and its significance. Lab Med. 2007;22:150-154.
28. Belinsky SA, Klinge DM, Dekker JD, et al: Gene promoter methylation in plasma and sputum increases with lung cancer risk.Clin Cancer Res. 2005;11:6505-6511.
29. Dong DQ, Yang YH, Xue DY, et al: Expression of survivin mRNA of sputum and pleural effusions in human lung cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006;31:848-852.
30. Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N: Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Lung cancer 2004;46:299-304.
31. Destro A, Bianchi P, Alloisio M, Laghi L, Di Gioia S, Malesci A, et al: K-ras and p16(INK4A) alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers. Lung Cancer 2004;44:23-32.
32. Keohavong P, Gao WM, Zheng KC, Mady H, Lan Q, Melhem M, et al: Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis. Anal Biochem. 2004;324:92-99.
33. Dorland's Illustrated Medical Dictionary, 27th ed. Philadelphia: WB Saunders; 1988:1570.
34. Choi YD, Han CW, Kim JH, Oh IJ, Lee JS, Nam JH, et al: Effectiveness of sputum cytology using ThinPrep method for evaluation of lung cancer. Diagn Cytopathol. 2008;36:167-171.